These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10983761)

  • 41. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I.
    Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P
    J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tc-99m MIBI uptake by a male breast lymphoma accompanied by diffuse bone marrow metastases.
    Du Y; Long Y; Ma R
    Clin Nucl Med; 1999 Jun; 24(6):454-5. PubMed ID: 10361949
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT; Rimkus DR; Hartzman S; Latimer RG
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 99mTc-MIBI in differentiated thyroid carcinoma.
    Roelants V; Beckers C
    J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520721
    [No Abstract]   [Full Text] [Related]  

  • 46. Technetium-99m sestamibi uptake in a maxillary brown tumor.
    Gayed IW; Elshazly SM; Vang RS; Barron BJ; Lamki LM
    Clin Nucl Med; 2001 Jan; 26(1):65-7. PubMed ID: 11139061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraoperative localization of parathyroid adenoma using 99Mtechnetium sestamibi.
    Burns C; Oppenheimer M; Wheeler K
    S D J Med; 1994 Jun; 47(6):202-4. PubMed ID: 8023130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost utility of routine imaging with Tc-99m-sestamibi in primary hyperparathyroidism before initial surgery.
    Wei JP; Burke GJ
    Am Surg; 1997 Dec; 63(12):1097-100; discussion 1100-1. PubMed ID: 9393259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel technique to improve the diagnostic yield of negative sestamibi scans.
    Nagar S; Walker DD; Embia O; Kaplan EL; Grogan RH; Angelos P
    Surgery; 2014 Sep; 156(3):584-90. PubMed ID: 24931283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-phase technetium-99m-sestamibi scanning to evaluate nodular thyroid malignancy.
    Alonso O; Mut F; Lago G
    J Nucl Med; 1996 Nov; 37(11):1919-20. PubMed ID: 8917213
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism.
    Matwichuk CL; Taylor SM; Wilkinson AA; Dudzic EM; Matte GG; Outerbridge CA; Schmon CL; Ihle SL
    J Am Vet Med Assoc; 1996 Nov; 209(10):1733-6. PubMed ID: 8921031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitivity of [99mTc]methoxyisobutylisonitrile scan in patients with metastatic differentiated thyroid cancer.
    Ronga G; Ventroni G; Montesano T; Filesi M; Ciancamerla M; Di Nicola AD; Travascio L; Vestri AR; Signore A
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):364-71. PubMed ID: 17473819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of thyroid pathology on the results of parathyroid gammagraphy with Tc(99m)-sestamibi.
    Piñero A; Rodriguez JM; Ortiz S; Claver MA; Parrilla P
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):655-6. PubMed ID: 11106929
    [No Abstract]   [Full Text] [Related]  

  • 56. Minimally invasive (99m)Tc-sestamibi radioguided surgery of parathyroid adenomas.
    Rubello D; Giannini S; De Carlo E; Mariani G; Muzzio PC; Rampin L; Pelizzo MR
    Panminerva Med; 2005 Jun; 47(2):99-107. PubMed ID: 16210995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid hemiagenesis.
    Sari O; Ciftçi I; Törü M; Erbaş B
    Clin Nucl Med; 2000 Oct; 25(10):766-8. PubMed ID: 11043712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules.
    Hurtado-López LM; Martínez-Duncker C
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1701-3. PubMed ID: 17581750
    [No Abstract]   [Full Text] [Related]  

  • 59. Visualization of papillary thyroid carcinoma and its metastatic lymph nodes. Images with Tc-99m pertechnetate, Tl-201, and Tc-99m sestamibi.
    Alper E; Akbunar T; Tamgac F
    Clin Nucl Med; 1996 Oct; 21(10):815-6. PubMed ID: 8896938
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.
    Scott AM; Kostakoglu L; O'Brien JP; Straus DJ; Abdel-Dayem HM; Larson SM
    J Nucl Med; 1992 Jul; 33(7):1396-8. PubMed ID: 1613584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.